Loading organizations...
Yonjin Venture LLC operates as an investment firm specializing in early- and mid-stage life science companies. It focuses on innovative technologies within therapeutics, diagnostics, and medical devices. The firm provides capital and strategic guidance to foster advancements, supporting growth for companies at critical development stages.
Established as the North American and European investment arm of the Yongjin Group, a Shanghai-headquartered financial organization including Yonghua Capital, Yonjin Venture LLC extends the parent group's reach. This structure allows for strategic capital deployment into Western life science markets, utilizing the larger group's financial foundation and investment acumen.
The firm partners with pioneering life science companies to accelerate scientific breakthroughs through sustained support. Yonjin Venture LLC’s vision is to become a leading investor in the life science sector, connecting innovative Western enterprises with the resources and strategic networks of its broader financial ecosystem.
Key people at Yonjin Capital.
Key people at Yonjin Capital.
Yonjin Capital has 9 tracked investments across 8 companies. The latest tracked deal is $53.0M Series D in CSA Medical in September 2024.